&nbsp;

Apr 2019

Drug

octreotide

Other Name(s): Sandostatin® (multiple brands available) , Sandostatin® LAR™ (Novartis)

Quick Link(s):

Aug 2016

Drug

leuprolide

Other Name(s): Lupron® , Lupron Depot® , Eligard®

Quick Link(s):

May 2025

Drug

lomustine

Other Name(s): CeeNU®

Quick Link(s):

Aug 2024

Drug

oBINutuzumab

Other Name(s): Gazyva®

Quick Link(s):

May 2022

Drug

lenvatinib

Other Name(s): Lenvima®

Quick Link(s):

Sep 2023

Drug

lanreotide

Other Name(s): Somatuline® Autogel®

Quick Link(s):

Jun 2024

Drug

osimertinib

Other Name(s): Tagrisso®

Quick Link(s):

Jan 2024

Drug

liposomal irinotecan

Other Name(s): Onivyde® (Baxalta Canada)

Quick Link(s):

Sep 2017

Regimen

LETR

Cancer Type:

Breast

Intent: Adjuvant

Funding:

ODB - General Benefit

letrozole

, Collapse Show fewer tags

Drugs Used:

letrozole

... Show more tags

Quick Link(s):

Regimen Monograph

Aug 2025

Regimen

LETR

Cancer Type:

Breast

Intent: Palliative

Funding:

ODB - General Benefit

letrozole

, Collapse Show fewer tags

Drugs Used:

letrozole

... Show more tags

Quick Link(s):

Regimen Monograph

Aug 2025

Regimen

LENA

Cancer Type:

Hematologic,

Myelodysplastic Syndrome (MDS)

Intent: Palliative

Funding:

ODB Limited Use

lenalidomide - For the treatment of patients with anemia due to myelodysplastic syndrome (MDS), according to clinical criteria